BioMarin Pharmaceutical Inc. buy StockNews.com
Start price
29.04.23
/
50%
€88.08
Target price
29.04.24
-
Performance (%)
-13.03%
End price
30.04.24
€76.60
Summary
This prediction ended on 30.04.24 with a price of €76.60. The prediction for BioMarin Pharmaceutical Inc. disappointed with a performance of -13.03%. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | -3.367% | -3.367% | -7.186% |
| iShares Core DAX® | 2,55 % | 0,56 % | 14,14 % |
| iShares Nasdaq 100 | 2,74 % | -0,60 % | 30,37 % |
| iShares Nikkei 225® | 6,58 % | 4,34 % | 49,37 % |
| iShares S&P 500 | 1,93 % | -0,51 % | 24,26 % |
Comments by StockNews_com for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€66.60
10.03.25
10.03.25
-
10.03.26
10.03.26
-21.50%
11.03.26
11.03.26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€67.70
02.03.25
02.03.25
-
02.03.26
02.03.26
-25.47%
03.03.26
03.03.26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€65.26
22.02.25
22.02.25
-
22.02.26
22.02.26
-17.99%
23.02.26
23.02.26